Relationship between Lifestyle, Body Mass Index, and Dietary Factors with the Equol Production
Tita H Madjid, AD Anwar, R Anwar, RD Angganiawati, K Mantilidewi, B Handono
Citation Information :
Madjid TH, Anwar A, Anwar R, Angganiawati R, Mantilidewi K, Handono B. Relationship between Lifestyle, Body Mass Index, and Dietary Factors with the Equol Production. J South Asian Feder Obs Gynae 2020; 12 (1):18-22.
Aim: This study was aimed to find the relationship between lifestyle factor (smoking and physical activity), body mass index, and dietary component with equol-producing phenotype. Our work can be useful as basic data to modify lifestyle and nutrition to improve the metabolism of equol production, which is needed for women's health. Materials and methods: Data were collected using interview and semiquantitative food frequency questionnaire. Equol was measured in urine and was collected after a 3-day soy challenge to determine equol-producing phenotypes. Results: Correlation analysis among lifestyle factors and dietary component with equol-production phenotpe was performed. Data show that equol producers accounted in 60.7% of the participants. Smoking was significantly correlated to equol-producing phenotype (p = 0.030; r = 0.224). Carbohydrate and dietary fiber were positively correlated with equol-producing phenotypes (p = 0.011; r = 0.202) and (p = 0.004; r = 0.218). No significant correlation observed between physical activity, BMI, dietary protein, and fat intake with equol-producing phenotypes (p = 0.677; r = 0.035), although we observed a lower dietary fat intake in equol producer compared to nonequol producer. Conclusion: These findings suggest that smoking habit, carbohydrate, and dietary fiber significantly influence equol-producing phenotypes. Clinical significance: Our study may be useful as basic data to modify lifestyle and nutrition to improve the metabolism of equol production, which is needed for women's health.
Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical Importance of the metabolite equol: a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132(12):3577–3584. DOI: 10.1093/jn/132.12.3577.
Atkinson C, Berman S, Humbert O, et al. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 2004;134(3):596–599. DOI: 10.1093/jn/134.3.596.
Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 2005;230(3):155–170. DOI: 10.1177/153537020523000302.
Rybak ME, Sternberg MR, Pfeiffer CM. Sociodemographic and lifestyle variables are compound- and class-specific correlates of urine phytoestrogen concentrations in the U.S. population. J Nutr 2013;143(6):986S–994S. DOI: 10.3945/jn.112.172981.
Frankenfeld CL, Atkinson C, Wähälä K, et al. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Eur J Clin Nutr 2014;68(4):526–530. DOI: 10.1038/ejcn.2014.23.
Setchell KDR, Brown NM, Summer S, et al. Dietary factors influence production of the soy isoflavone metabolite S-(−)equol in healthy adults. J Nutr 2013;143(12):1950–1958. DOI: 10.3945/jn.113. 179564.
Liu W, Tanabe M, Harada KH, et al. Levels of urinary isoflavones and lignan polyphenols in Japanese women. Environ Health Prev Med 2013;18(5):394–400. DOI: 10.1007/s12199-013-0338-6.
Allais L, Kerckhof FM, Verschuere S, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol 2015;18(5):1352–1363. DOI: 10.1111/1462-2920.12934.
Wu X, Cai H, Gao YT, et al. Correlations of urinary phytoestrogen excretion with lifestyle factors and dietary intakes among middle-aged and elderly Chinese women. Int J Mol Epidemiol Genet 2012;3(1):18–29.
Kotzampassi K, Giamarellos-Bourboulis EJ, Stavrou G. Obesity as a consequence of gut bacteria and diet interactions. ISRN Obes 2014;2014:651895. DOI: 10.1155/2014/651895.
Yuan JP, Wang JH, Liu X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora—implications for health. Mol Nutr Food Res 2007;51(7):765–781. DOI: 10.1002/mnfr.200600262.
Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013;5(4):1417–1435. DOI: 10.3390/nu5041417.
Parnell JA, Reimer RA. Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 2012;3(1):29–34. DOI: 10.4161/gmic. 19246.
Lopez-Legarrea P, Fuller NR, Zulet MA, et al. The influence of mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pacific J Clin Nutr 2014;23(3):360–368.
Russell WR, Gratz SW, Duncan SH, et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 2011;93(5):1062–1072. DOI: 10.3945/ajcn.110.002188.
Rowland IR, Wiseman H, Sanders TA, et al. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000;36(1):27–32. DOI: 10.1207/S15327914NC3601_5.
Moreira APB, Texeira TF, Ferreira AB, et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012;108(5):801–809. DOI: 10.1017/S0007114512001213.
Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterolgy 2009;137(5):1716–24.e1-2. DOI: 10.1053/j.gastro.2009.08.042.